MRD Ad Board

DeciBio conducted ~11 interviews with medical oncologists and biopharma executives to understand how minimal residual disease (MRD) testing and ctDNA monitoring are currently integrated into solid tumor care
Publish Date
February 8, 2023
Category
Ad Board Reports
Price
$ 2,750.00 USD
Publish Date
February 8, 2023
Category
Ad Board Reports
Price
$ 2,750.00 USD
Publish Date
February 8, 2023
Category
Ad Board Reports
Price
$ 2,750.00 USD

DeciBio conducted ~11 interviews with medical oncologists and biopharma executives to understand how minimal residual disease (MRD) testing and ctDNA monitoring are currently integrated into solid tumor care. Key themes discussed include overviews of which indications have the most MRD/monitoring clinical utility, top selection criteria for ctDNA assays, feedback related to assay vendors, and drivers / moderators relevant to increased use.This report provides a qualitative summary of these interviews. In response to each key interview question, DeciBio provides several condensed takeaways and a curated list of quotes indicative of stakeholder feedback.

This report is organized around the responses to 15 key study questions


  • How is MRD / monitoring testing implemented clinically today?
  • Which indications currently have the most MRD clinical utility and how has test adoption impacted patient care?
  • Which indications currently have the most ctDNA monitoring clinical utility and how has test adoption impacted patient care?
  • What is the clinical utility of MRD / monitoring tests today on a scale of 1-5 (1 =very low utility, 5 = very high utility)?
  • Which test features /characteristics are most important when selecting an MRD assay?
  • Which test features /characteristics are most important when selecting a ctDNA monitoring assay?
  • What are the top 5 selection criteria you evaluate when selecting an MRD or ctDNA monitoring assay?
  • What do you see as key differentiating features for MRD / Monitoring today tests today?
  • What are the top pain points associated with MRD testing today and what has been your experience adopting this technology?
  • What are the top pain points associated with ctDNA monitoring tests today and what has been your experience adopting this technology?
  • What do you believe are the optimal solutions to current ctDNA MRD/ monitoring pain points?
  • Do you have a preference between  tumor-informed vs tumor-agnostic approaches?
  • Which ctDNA MRD / monitoring assay vendors are you  most familiar with?
  • What are the strengths / weaknesses  across each of the MRD / monitoring vendors you have used?
  • Do you expect any changes to the  vendors you use for ctDNA MRD / monitoring over the next  ~12 months?

Companies Discussed

  • C2i
  • Foundation Medicine
  • Guardant Health
  • Invitae / ArcherDx
  • Natera
  • NeoGenomics / Inivata
  • Personalis
  • Others

Purchase Options

Summary Report
PDF deck with summarized feedback from stakeholders
Interview Transcripts
Individual PDFs of call transcripts with stakeholders
Report + Transcript Bundle
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
Browse Individual Transcripts
Individual call transcript of a single stakeholder discussing their views. This option is ideal for those who are interested in a specific stakeholder's perspective and insights on the topic.
Summary Report
PDF deck with summarized feedback from stakeholders
Interview Transcripts
Individual PDFs of call transcripts with stakeholders
Report + Transcript Bundle
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
Price
$ 2,750.00 USD
To claim your free report, simply fill out the form below with your contact information, and we’ll send it to you right away. Don’t miss out on this opportunity to gain a competitive edge in your industry. Sign up now!
Request Access
Summary Report
PDF deck with summarized feedback from stakeholders
Interview Transcripts
Individual PDFs of call transcripts with stakeholders
Report + Transcript Bundle
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
Price
$ 2,750.00 USD
Price
$ 2,750.00 USD
Summary Report
PDF deck with summarized feedback from stakeholders
Interview Transcripts
Individual PDFs of call transcripts with stakeholders
Report + Transcript Bundle
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
Price
$ 2,750.00 USD

Experience the DeciBio Difference

Engage with our experts at DeciBio to discover how our tailored solutions can meet your unique needs.
Request Demo Today

Experience the DeciBio Difference

Engage with our experts at DeciBio to discover how our tailored solutions can meet your unique needs.
Request Demo Today
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch